# Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo

> **NCT01308619** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 170 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Doxycycline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01308619
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01308619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01308619, "Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01308619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*